CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,993 | $5.70 | $11K | 350,844 |
| 2017-07-01 | Fardis Maria President and CEO | Shares withheld for taxes | −1,994 | $7.35 | $15K | 352,837 |
| 2017-06-01 | Fardis Maria President and CEO | Shares withheld for taxes | −143,496 | $5.45 | $782K | 354,831 |
| 2017-06-01 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2017-06-01 | MCPEAK MERRILL A Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2017-06-01 | Maynard Ryan D Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2017-06-01 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2017-06-01 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2017-04-03 | Fardis Maria President and CEO | Shares withheld for taxes | −51,673 | $7.15 | $369K | 498,327 |
| 2016-11-14 | SCHIFFMAN GREGORY T Chief Financial Officer | Grant or award · Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2016-08-25 | Hillsberg Sanford Director | Sale | −20,500 | $8.71 | $179K | 100,000 |
| 2016-08-24 | Hillsberg Sanford Director | Sale | −33,500 | $9.10 | $305K | 120,500 |
| 2016-08-22 | Hillsberg Sanford Director | Sale | −54,000 | $9.11 | $492K | 100,000 |
| 2016-08-16 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +70,000 | 70,000 | ||
| 2016-08-16 | Fardis Maria President and CEO | Other acquisition · Stock Option (right to buy) | +0 | 0 | ||
| 2016-08-16 | Dukes Iain D. Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-08-16 | Hillsberg Sanford Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-08-16 | Venkatesan Jay Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-08-16 | Maynard Ryan D Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2016-08-16 | MCPEAK MERRILL A Director | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 |
Page 26 of 31 · 605 trades